Abbott Laboratories vs. Chemomab Therapeutics Ltd. American Depositary Share
ABT
Abbott Laboratories
$102.83 +0.58%
VS CMMBChemomab Therapeutics Ltd. American Depositary Share
$2.69 -2.18%
Abbott Laboratories and Chemomab Therapeutics Ltd. American Depositary Share are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | CMMB | |
|---|---|---|
| Market Cap | $176.90 billion | $20.15 million |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | — |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | CMMB | |
|---|---|---|
| P/E Ratio | 33.28 | — |
| Price / Book | 3.42 | — |
| Price / Sales | 3.80 | — |
ABT and CMMB split the valuation factors evenly.
Profitability
| ABT | CMMB | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | — |
ABT and CMMB split the profitability factors evenly.
Dividend
| ABT | CMMB | |
|---|---|---|
| Dividend Yield | 2.45% | — |
| Payout Ratio | 81.55 | — |
ABT and CMMB split the dividend factors evenly.
Risk & Sentiment
| ABT | CMMB | |
|---|---|---|
| Short Interest | 0.57% | 0.17% |
CMMB leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, CMMB overview, CMMB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.